Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.

by

Call 1 (888) 460-6556 to speak with a counselor.

Authors: Balhara YP
PMID: 24380101 [PubMed – indexed for MEDLINE] (Source: Journal of Opioid Management)

Previous post: Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.

Next post: Considerations on the role of buprenorphine in recovery from heroin addiction from a UK perspective

All About Suboxone | Oxycontin Treatment Directory | About | Disclaimer | Privacy Policy| Built On The Thesis Theme for WordPress

Get Help

Call 877-841-0923 Now!

X